Um

UM Names Deidre Smalls-Landau U.S. Chief Marketing Officer and EVP, Global Culture

Retrieved on: 
Tuesday, August 6, 2019

NEW YORK, Aug. 6, 2019 /PRNewswire/ -- UM, the global marketing and media agency network of IPG Mediabrands, today announced the appointment of Deidre Smalls-Landau to the role of U.S. Chief Marketing Officer, effective immediately.

Key Points: 
  • NEW YORK, Aug. 6, 2019 /PRNewswire/ -- UM, the global marketing and media agency network of IPG Mediabrands, today announced the appointment of Deidre Smalls-Landau to the role of U.S. Chief Marketing Officer, effective immediately.
  • "As a key member of the UM team, Deidre has worked relentlessly to strengthen the agency's product and culture by positioning diversity as a true competitive advantage that can help drive business results," said Lewis.
  • Under Smalls-Landau's leadership, UM launched Remix Culture , the first culturally-focused iteration of its annual Wave X study that tracks social and digital media usage and motivations globally.
  • UM is a strategic media agency committed to proving that media is a topline growth driver as much as an efficiency play.

UM Closes Offices Worldwide for Second Annual Global Impact Day

Retrieved on: 
Thursday, July 25, 2019

NEW YORK, July 25, 2019 /PRNewswire/ -- UM , the global marketing and media agency network of IPG Mediabrands, today announced the launch of its second annual Global Impact Day.

Key Points: 
  • NEW YORK, July 25, 2019 /PRNewswire/ -- UM , the global marketing and media agency network of IPG Mediabrands, today announced the launch of its second annual Global Impact Day.
  • More than 80 UM offices will close their doors for the day as employees volunteer at philanthropic organizations around the world.
  • UM employees will share Impact Day content on social media using hashtags #UMBetterWorld and #UMImpactDay.
  • "Impact Day has become an integral part of the DNA at UM, bonding employees to each other, to the agency and to their communities," said Anthony Hello, Senior Vice President and Better World Global Chair, UM.

University of Montana Strengthens Its Support for Researchers Through Ex Libris Esploro

Retrieved on: 
Saturday, January 26, 2019

CHICAGO, Jan. 26, 2019 /PRNewswire/ --Ex Libris, a ProQuest company, is pleased to announce that the University of Montana (UM) has opted for the ExLibris Esploro research services solution.

Key Points: 
  • CHICAGO, Jan. 26, 2019 /PRNewswire/ --Ex Libris, a ProQuest company, is pleased to announce that the University of Montana (UM) has opted for the ExLibris Esploro research services solution.
  • "The Esploro solution will greatly improve the UM libraries' support for research endeavors and will integrate library workflows and processes with the research office.
  • We are excited to welcome the University of Montana as an early adopter of Esploro."
  • The University of Montana (UM) is a place where top-tier students, educators, and researchers from across the country and around the globe come and thrive.

UM Names Lynn Lewis New U.S. CEO

Retrieved on: 
Tuesday, December 4, 2018

NEW YORK, Dec. 3, 2018 /PRNewswire-PRWeb/ -- UM, a division of IPG Mediabrands, announced today the appointment of Lynn Lewis to U.S. CEO.

Key Points: 
  • NEW YORK, Dec. 3, 2018 /PRNewswire-PRWeb/ -- UM, a division of IPG Mediabrands, announced today the appointment of Lynn Lewis to U.S. CEO.
  • An employee of fifteen years standing at UM, Lewis has held multiple leadership positions throughout the agency.
  • "I am incredibly proud to name Lynn as U.S. CEO," said Daryl Lee, global CEO, UM.
  • Prior to taking the helm at J3, she worked as the global managing partner on Sony at UM.

ImmuCision BioTherapeutics Receives Quick Financial Backing, Locates in University of Maryland BioPark

Retrieved on: 
Wednesday, September 5, 2018

BALTIMORE, Sept. 5, 2018 /PRNewswire/ -- The University of Maryland (UM) BioPark and UM Ventures announced today that ImmuCision BioTherapeutics (ICBT), a UM, Baltimore startup company specializing in immunotherapy, has established offices and laboratory space in the BioPark.

Key Points: 
  • BALTIMORE, Sept. 5, 2018 /PRNewswire/ -- The University of Maryland (UM) BioPark and UM Ventures announced today that ImmuCision BioTherapeutics (ICBT), a UM, Baltimore startup company specializing in immunotherapy, has established offices and laboratory space in the BioPark.
  • "ImmuCision has developed an innovative method that can significantly improve the growth (and quality) of dendritic cells in the lab.
  • Launched in 2017, ICBT has obtained a license from the University of Maryland, Baltimore for proprietary ihv-DC technology, which allows the immortalization of dendritic cells.
  • The UM BioPark is a biomedical research park on the campus of the University of Maryland, Baltimore (UMB).